Chloroethylclonidine is an irreversible agonist for adrenergic receptors, in particular alpha1B, D, C and alpha2A/D-subtypes.[1]

Chloroethylclonidine
Clinical data
ATC code
  • none
Identifiers
  • N-[2,6-Dichloro-4-[(2-chloroethyl-methylamino)methyl]phenyl]-4,5-dihydro-1H-imidazol-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.163.420 Edit this at Wikidata
Chemical and physical data
FormulaC13H17Cl3N4
Molar mass335.66 g·mol−1
3D model (JSmol)
  • ClCCN(C)Cc2cc(Cl)c(N/C1=N/CCN1)c(Cl)c2
  • InChI=1S/C13H17Cl3N4/c1-20(5-2-14)8-9-6-10(15)12(11(16)7-9)19-13-17-3-4-18-13/h6-7H,2-5,8H2,1H3,(H2,17,18,19) ☒N
  • Key:XFDVJGKSQRUEEM-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

References

edit
  1. ^ Docherty JR, O'Rourke M (February 1997). "The alpha-adrenoceptor-mediated actions of chloroethylclonidine". General Pharmacology. 28 (2): 197–201. doi:10.1016/s0306-3623(96)00187-5. PMID 9013194.